4.5 Article

High Expression of CX3CL1/CX3CR1 Axis Predicts a Poor Prognosis of Pancreatic Ductal Adenocarcinoma

Related references

Note: Only part of the references are listed.
Review Pharmacology & Pharmacy

Fractalkine/CX3CR1: why a single chemokine-receptor duo bears a major and unique therapeutic potential

Jan G. D'Haese et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2010)

Review Oncology

Perineural Invasion in Cancer A Review of the Literature

Catherine Liebig et al.

CANCER (2009)

Letter Oncology

Nonmetastatic pancreatic cancer: Many trials, little progress

Joerg Kleeff et al.

JOURNAL OF CLINICAL ONCOLOGY (2008)

Article Oncology

Chemokine CXCL12 and its receptor CXCR4 expression are associated with perineural invasion of prostate cancer

Shiwu Zhang et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2008)

Article Oncology

Cancer statistics, 2007

Ahmedin Jemal et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2007)

Article Neurosciences

Control of microglial neurotoxicity by the fractalkine receptor

Astrid E. Cardona et al.

NATURE NEUROSCIENCE (2006)

Article Neurosciences

Fractalkine and fractalkine receptors in human neurons and glial cells

K Hatori et al.

JOURNAL OF NEUROSCIENCE RESEARCH (2002)

Review Oncology

Pancreatic cancer: State-of-the-art care

KD Lillemoe et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2000)